0001415889-22-006742.txt : 20220617
0001415889-22-006742.hdr.sgml : 20220617
20220617163014
ACCESSION NUMBER: 0001415889-22-006742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bonstein Sara
CENTRAL INDEX KEY: 0001604019
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 221024281
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-06172022_040601.xml
X0306
4
2022-06-15
0001840233
Xilio Therapeutics, Inc.
XLO
0001604019
Bonstein Sara
828 WINTER STREET
SUITE 300
WALTHAM
MA
02451
true
false
false
false
Stock Option (right to buy)
2.28
2022-06-15
4
A
0
13200
0
A
2032-06-14
Common Stock
13200
13200
D
The option award was granted on June 15, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 15, 2023 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to as a director of the Issuer through the vesting date.
/s/ Chris Frankenfield, Attorney-in-Fact
2022-06-17